Commentary: How to Evaluate the Effect of Neoadjuvant Therapy for Esophageal Cancer? More Studies Are Still Needed
Haiquan Chen
DOI: https://doi.org/10.1016/j.jtcvs.2020.09.109
2021-01-01
Abstract:Central MessageMore work is needed to increase the accuracy of preoperative evaluation for esophageal cancer. The treatment decision should be made for the best survival.See Article page 1632. More work is needed to increase the accuracy of preoperative evaluation for esophageal cancer. The treatment decision should be made for the best survival. See Article page 1632. In the Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS), pathologic complete response was observed in 28 of 121 patients with adenocarcinoma (23%), and 18 of 37 with squamous-cell carcinoma (49%), the survival benefit was more pronounced in patients with esophageal squamous cell carcinoma.1van Hagen P. Hulshof M.C. van Lanschot J.J. Steyerberg E.W. van Berge Henegouwen M.I. Wijnhoven B.P. et al.Preoperative chemoradiotherapy for esophageal or junctional cancer.N Engl J Med. 2012; 366: 2074-2084Crossref PubMed Scopus (3852) Google Scholar However, the characteristics of residual tumors were not fully investigated in the CROSS study. In a cohort of patients with esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy (nCRT), Tang and colleagues2Tang H. Jiang D. Zhang S. Zeng Z. Tan L. Hou Y. et al.Zhongshan NCRT-EC working group. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.J Thorac Cardiovasc Surg. 2021; 162: 1632-1641Abstract Full Text Full Text PDF Scopus (10) Google Scholar present the pattern of residual tumors into 4 types: I, regression toward the lumen; II, regression toward the invasive front; III, concentric regression; and IV, scattered regression. Moreover, the frequency of pathological complete response was lower in the lymph nodes (29.2%) than in primary lesions (33.6%). According to the pattern of tumor regression and amount of the residual tumors, 62.7% could not be detected due to potentially negative biopsy in the superficial layer. Based on pathology results, the authors investigated the characteristics of tumor regression after nCRT, offering novel information for the treatment of esophageal cancer after nCRT. However, a clinical question arises: How to predict the type of tumor regression by preoperative workup? The relation between clinical and pathologic tumor responses is crucial in treatment decision making for patients with esophageal cancer. To evaluate the effect of neoadjuvant therapy, the Detection of Residual Disease After Neoadjuvant Chemoradiotherapy for Oesophageal Cancer (preSANO) study was initiated to evaluate the accuracy of different diagnostic techniques for clinical response evaluations. However, with the combination of endoscopic ultrasonography, bite-on-bite biopsies, and fine-needle aspiration, 25 of 47 tumor regression grade (TRG) 1 or 2 tumors (53.2%) and 4 of 41 TRG 3 or 4 tumors (9.8%) were still missed.3Noordman B.J. Spaander M.C.W. Valkema R. Wijnhoven B.P.L. van Berge Henegouwen M.I. Shapiro J. et al.Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.Lancet Oncol. 2018; 19: 965-974Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar Thus, more work is needed to increase the accuracy of disease evaluation, particularly for TRG 1 or 2 patients. Regarding the treatment decision after nCRT, the optimal strategy should be made for a better survival, which is the most important outcome. For this aim, the ongoing Surgery as Needed Approach in Oesophageal Cancer Patients (SANO) trial compared active surveillance with standard resection for patients who achieve a complete response after nCRT,4Noordman B.J. Wijnhoven B.P.L. Lagarde S.M. Boonstra J.J. Coene P.P.L.O. Dekker J.W.T. et al.Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.BMC Cancer. 2018; 18: 142Crossref PubMed Scopus (144) Google Scholar and active surveillance could be a kind of standard care if this strategy leads to noninferior survival. Due to the difficulties in tumor regression evaluation, on the other hand, compared with neoadjuvant therapy, postoperative adjuvant therapy was delivered based on accurate pathological staging rather than inaccurate clinical staging. In the trial comparing esophagectomies via right and left thoracic approach, which was performed under the policy of surgery plus adjuvant therapy, 5-year overall survival was 63% after esophagectomy with radical 2-field lymphadenectomy via right thoracic approach, and 51% for those with lymph node metastasis.5Li B. Hu H. Zhang Y. Zhang J. Miao L.S. Ma L.F. et al.Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial.Ann Surg. 2018; 267: 826-832Crossref PubMed Scopus (50) Google Scholar,6Li B. Hu H. Zhang Y. Zhang J. Sun Y.H. Xiang J.Q. et al.Esophageal squamous cell carcinoma patients with positive lymph nodes benefit from extended radical lymphadenectomy.J Thorac Cardiovasc Surg. 2019; 157: 1275-1283.e1Abstract Full Text Full Text PDF PubMed Scopus (12) Google Scholar Thus, new trials comparing neoadjuvant and adjuvant treatment for esophageal squamous cell carcinoma are needed. More work is needed to increase the accuracy of clinical disease staging and evaluation of tumor regression response. For patients with esophageal cancer, the optimal treatments should be established based on prospective evidence with the best outcomes. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapyThe Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 6PreviewThe study was to investigate the characteristics of residual tumors of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. Full-Text PDF